暂无数据
暂无内容
暂无数据
暂无数据
暂无数据
ABCellera与私募股权公司合作开发抗体药物,创建公司
Seeking Alpha05/01 11:44 (美东)
快讯 | Abcellera:根据条款,Abcellera将作为股权创始合伙人参与,有可能实现里程碑,每种产品未来销售的特许权使用费
Reuters05/01 09:11 (美东)
快讯 | Abcellera Biologics Inc:根据合作条款,Viking和ArrowMark将成为Newcos的大股东
Reuters05/01 09:10 (美东)
快讯 | Abcellera、Viking Global Investors和ArrowMark Partners合作推出新的生物技术公司
Reuters05/01 09:00 (美东)
机构所有者可能会考虑采取严厉措施,因为Abcellera Biologics Inc.s(纳斯达克股票代码:ABCL)最近下跌了9100万美元,增加了长期损失
关键见解鉴于机构持有该股的大量股份,Abcellera Biologics的股价可能容易受到其交易决策的影响 50%的业务由前8名股东持有
Simply Wall St04/22 06:42 (美东)
ABCellera 在 AACR 2024 上公布了对抗四个肿瘤靶标的 T 细胞参与者的数据
Business Wire04/08 12:05 (美东)
Trytosaveabit楼主 PYUN970IHaveChosen: Yeah right! That’s a litter bit more than it’s trading?
PYUN970IHaveChosen Trytosaveabit楼主: Watching. Still laughing about this GVH all over the place today.
Trytosaveabit楼主 PYUN970IHaveChosen: I Stayed away from it! Don’t know why i didn’t like it? But i didn’t. Hehehe
PYUN970IHaveChosen Trytosaveabit楼主: Well I did most of the day and then just watched it plummet to 2.56 several times so I couldn’t help myself to grab a few at that price. WeBuy was doing good so I grabbed a few with some SMALL gains.
暂无数据
暂无数据